• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Model Number FT4 G3
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Lot no continued: asku for 1 of the events, the customer stated that the patient result comparability between the cobas e601 and an abbott system was improved after performing preventative maintenance.As the patient sample was not available for further investigation, the specific cause of the event could not be determined.The investigation did not identify a product problem.For 2 of the events, the investigation is ongoing.For 1 of the events, from the information provided, a general reagent issue can be excluded.Assays from different manufacturers can generate different results.This relates to the overall setups of the assays, the antibodies used, differences in reference materials and the standardization methodology used.The investigation did not identify a product problem.For 1 of the events, an interfering factor could not be identified.The investigation did not identify a product problem.The cause of the event could not be determined.For 2 of the events, assays from different vendors can generate different values.This relates to the overall setups of the assays, the antibodies used, differences in reference materials/methods, and differences in the standardization methodology used.For 1 of the events, preventative maintenance was performed on the analyzer.For 1 of the events, the sample was provided for investigation.No devices were returned.This device is not labeled for single use and is not reprocessed or reused.
 
Event Description
This report summarizes 7 malfunction events.Questionable high results were generated by a cobas 6000 e 601 module compared to an abbott, a cobas 8000 e 602 module, and a cobas 8000 e 602 module compared to an abbott system.The events involved a total of 7 patients with elecsys ft4 iii assay.The provided patients' ages ranged from 28 to "60s" years.The other patients' ages were requested but were not provided.The patients' weights were requested but were not provided.There were 2 females and 1 male.The other patients' genders were requested but were not provided.The patients' races were requested but were not provided.The patients' ethnicities were requested but were not provided.
 
Manufacturer Narrative
For one of the pending events, the investigation could not identify a product problem.The cause of the event could not be determined.There were no follow up actions for this event.For the one other pending event, sample form the patient was investigated.An interfering factor against sa could be excluded in this sample the investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 III ASSAY
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
MDR Report Key9238182
MDR Text Key219401963
Report Number1823260-2019-90250
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
Number of Events Reported7
Summary Report (Y/N)Y
Report Source Manufacturer
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator No Information
Device Model NumberFT4 G3
Device Lot Number391521, 410248
Initial Date Manufacturer Received Not provided
Initial Date FDA Received10/25/2019
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/15/2020
Patient Sequence Number1
-
-